Ennio Giulio Favalli

InstitutionGaetano Pini Institute
AddressMilan
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 18 Covid-19 publications, with a maximum of 5 publications in April 2020
    All Publications
    Bar chart showing 81 publications over 16 distinct years, with a maximum of 15 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Favalli EG, Maioli G, Biggioggero M, Caporali R. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic. Expert Rev Clin Immunol. 2021 06; 17(6):561-571. PMID: 33787418.
      Citations: 3     Fields:    Translation:Humans
    2. Ingegnoli F, Cincinelli G, Luppino AF, Favalli EG, Orenti A, Boracchi P, Caporali R. Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy. Ann Rheum Dis. 2021 09; 80(9):1243-1245. PMID: 33849919.
      Citations: 1     Fields:    Translation:Humans
    3. Batticciotto A, Marotto D, Giorgi V, Balzarini P, Favalli EG, Balduzzi S, Fredi M, Bazzani C, Sartorelli S, Ravagnani V, Tamanini S, Castelnovo L, Lurati AM, Farah S, Bongiovanni S, Caporali R, Dagna L, Faggioli P, Franceschini F, Montecucco CM, Salaffi F, Galli M, Cappelli A, Sarzi-Puttini P. Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection. Clin Exp Rheumatol. 2021 May-Jun; 39(3):695. PMID: 33635224.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Favalli EG, Bugatti S, Klersy C, Biggioggero M, Rossi S, De Lucia O, Bobbio-Pallavicini F, Murgo A, Balduzzi S, Caporali R, Montecucco C. Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis. Arthritis Res Ther. 2020 12 30; 22(1):290. PMID: 33380344.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    5. Sarzi-Puttini P, Marotto D, Caporali R, Montecucco CM, Favalli EG, Franceschini F, Fredi M, Balduzzi S, Bazzani C, Bongiovanni S, Giorgi V, Batticciotto A, Cappelli A, Balzarini P, Dagna L, Sartorelli S, Ravagnani V, Tamanini S, Farah S, Faggioli P, Castelnovo L, Lurati AM, Galli M, Salaffi F. Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study. J Autoimmun. 2021 01; 116:102545. PMID: 32972804.
      Citations: 9     Fields:    Translation:Humans
    6. Favalli EG, Monti S, Ingegnoli F, Balduzzi S, Caporali R, Montecucco C. Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data? Arthritis Rheumatol. 2020 10; 72(10):1600-1606. PMID: 32506699.
      Citations: 34     Fields:    Translation:Humans
    7. Favalli EG, Ingegnoli F, Biggioggero M, Caporali R. Is there really room for anti-rheumatic drugs in the treatment of COVID-19? Scand J Rheumatol. 2020 09; 49(5):412-413. PMID: 32720847.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    8. Favalli EG, De Lucia O, Biggioggero M, Del Papa N, Caporali R. Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients. Ann Rheum Dis. 2021 05; 80(5):e75. PMID: 32561608.
      Citations: 5     Fields:    Translation:Humans
    9. Favalli EG, Caporali R. GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm? Lancet Rheumatol. 2020 Aug; 2(8):e448-e449. PMID: 33521666.
      Citations: 2     
    10. Favalli EG, Agape E, Caporali R. Dr. Favalli, et al reply. J Rheumatol. 2020 10 01; 47(10):1592. PMID: 32482654.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    11. Favalli EG, Gerosa M, Murgo A, Caporali R. Are patients with systemic lupus erythematosus at increased risk for COVID-19? Ann Rheum Dis. 2021 02; 80(2):e25. PMID: 32451344.
      Citations: 12     Fields:    Translation:HumansCells
    12. Coletto LA, Favalli EG, Caporali R. Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days. Dermatol Ther. 2020 07; 33(4):e13415. PMID: 32291828.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    13. Caporali R, Favalli EG. Managing patients with rheumatic conditions during the covid-19 pandemic. BMJ. 2020 04 27; 369:m1633. PMID: 32340996.
      Citations: 2     Fields:    
    14. Favalli EG, Agape E, Caporali R. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis. J Rheumatol. 2020 08 01; 47(8):1296. PMID: 32335513.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    15. Licciardi F, Giani T, Baldini L, Favalli EG, Caporali R, Cimaz R. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatr Rheumatol Online J. 2020 Apr 22; 18(1):35. PMID: 32321540.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    16. Favalli EG, Ingegnoli F, Cimaz R, Caporali R. What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. 2021 02; 80(2):e18. PMID: 32321723.
      Citations: 38     Fields:    Translation:Humans
    17. Favalli EG, Biggioggero M, Maioli G, Caporali R. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 2020 09; 20(9):1012-1013. PMID: 32251638.
      Citations: 74     Fields:    Translation:HumansCellsPHPublic Health
    18. Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev. 2020 May; 19(5):102523. PMID: 32205186.
      Citations: 162     Fields:    Translation:HumansCellsPHPublic Health
    Favalli's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (132)
    Explore
    _
    Co-Authors (57)
    Explore
    _
    Similar People (60)
    Explore
    _